This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,409.59 Delivery Order is for the supply of XELJANZ XR 11 MG TABLET with a performance period through December 3, 2024. This award is associated with AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary mechanism for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contracts demonstrate AmerisourceBergen's critical role in supplying essential pharmaceuticals and medical commodities to various federal government agencies, including the military and veterans' healthcare systems.
Generated 3/9/25, 12:48 AM